• Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of the Naval Medical University, Changhai Hospital, Shanghai 200433, P. R. China;
BAI Chong, Email: bc7878@sohu.com
Export PDF Favorites Scan Get Citation

Objective To introduce implantation methods of different types of congenital heart disease occluder for the treatment of bronchopleural fistula (BPF) and its preliminary efficacy.Methods Three patients who diagnosed with BPF and treated by congenital heart disease occluder were reviewed. The clinical data was analyzed after comprehensively reviewing of relevant literature.Results All the three patients were treated with postoperative BPF and empyema. The diameter of the fistula ranged from 3 to 8 mm. We used occlusive devices for congenital heart diseases such as atrial septum (ASD), ventricular septum (VSD) defect or patent ductus arteriosus (PDA), respectively. After treatment, all three patients were cured of BPF and empyema caused by BPF in a short time, and the thoracic drainage tube was successfully removed. During the follow-up period from 7 to 25 months, no significant long-term complications were observed.Conclusion The use of ASD, VSD and PDA occluder for the treatment of BPF with a fistula more than 3 mm is effective and safe.

Citation: WANG Xiangqi, HUANG Haidong, ZHANG Wei, DONG Yuchao, XIA Ying, WANG Qin, BAI Chong. Application of different types of congenital heart disease occluder in bronchopleural fistula. Chinese Journal of Respiratory and Critical Care Medicine, 2021, 20(1): 37-41. doi: 10.7507/1671-6205.201911070 Copy

  • Previous Article

    Effects of short-time hyperoxia ventilation on lung tissue and pulmonary surfactant proteins C and D in rats
  • Next Article

    Clinical characteristics and risk factors of combined pulmonary fibrosis and emphysema syndrome